DSIP has been studied in neurological contexts, but that does not mean it improves brain function in healthy people
Analyst Opinion "GLP-1 hydration is emerging as a support category rather than a novelty beverage trend
These trials showed that tirzepatide reduced fasting plasma glucose and HbA 1c levels not only compared with placebo but also compared with the insulins degludec and glargine or semaglutide [90,91,92]
That made logical sense to me
Its a catastrophic, yet completely avoidable, outcome
GLP-1 medications like Mounjaro, Wegovy and Ozempic have become a popular tool for weight management, with an estimated 1.6 million people using them in Great Britain alone.[1] While these medications can be highly effective for supporting weight loss, theres evidence that weight regain is common after treatment stops.[2] This is because GLP-1 medications work by reducing appetite and supporting metabolic processes that make it easier to lose weight